While French Investigation into COVID-19 Vaccine Deaths Centralizes, the Data Overwhelmingly Suggests Lack of Vaccination Leads to Far Greater Risk

While French Investigation into COVID-19 Vaccine Deaths Centralizes the Data Overwhelmingly Suggests Lack of Vaccination Leads to Far Greater Risk

Prosecutors in France are investigating three separate investigations into three deaths allegedly connected with the AstraZeneca COVID-19 vaccination. Specific prosecutors, experts in complex investigations involving health-related products, now engage in an initial probe of existing complaints filed in Toulouse, Paris and Nates. To date, these complaints have been managed by regional prosecutors. Plaintiff-side prosecutors out of Paris now seek to determine if there is any causal role between the AstraZeneca vaccine and the deaths. Apparently, an attorney behind the complaints reported to AFP that they first engaged with local prospectors to accelerate the process and then requested that the case be transferred to the central investigation in Paris. TrialSite notes that the risk of a blood clot from the AstraZeneca vaccine is incredibly low—a truly rare occurrence. In fact, a Health Minister from France, Olivier Veran, was quoted earlier this month, “You are 50 times more likely to get a vein blood clot crossing the Atlantic by plane than getting vaccinated with AstraZeneca. Vaccines protect us from COVID-19. Let’s not give into mistrust!” In another European study, a group of re...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee